HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma

P Maroto,1 E Esteban,2 E Fernández Parra,3 MJ Mendez-Vidal,4 M Domenech,5 B Pérez-Valderrama,6 V Calderero,7 JL Pérez-Gracia,8 E Grande,9 F Algaba10 1Department of Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, 2Department of Oncology, Nuevo HUCA, Oviedo...

Full description

Bibliographic Details
Main Authors: Maroto P, Esteban E, Fernández Parra E, Mendez-Vidal MJ, Domenech M, Pérez-Valderrama B, Calderero V, Pérez-Gracia JL, Grande E, Algaba F
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:OncoTargets and Therapy
Subjects:
c-Myc
Clear-cell renal cell carcinoma
HIF
Sunitinib
Online Access:https://www.dovepress.com/hif-pathway-and-c-myc-as-biomarkers-for-response-to-sunitinib-in-metas-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/hif-pathway-and-c-myc-as-biomarkers-for-response-to-sunitinib-in-metas-peer-reviewed-article-OTT

Similar Items